itical illness, and voluntary benefits products. Unum UK's products are issued primarily by Unum Limited and are sold in the United Kingdom through field sales personnel and independent brokers and consultants. Group Long-term Disability: Group long-term disability products are sold to employers for the benefit of employees. Group long-term disability provides employees with insurance coverage for loss of income in the event of extended work absences due to sickness or injury. Services are offered to employers and insureds to encourage and facilitate rehabilitation, retraining, and re-employment. Most policies begin providing benefits following 90 or 180 day waiting periods and continue providing benefits until the employee reaches a certain age, generally between 60 and 67. Group Life: Group life products are sold to employers as employee benefit products. Group life consists of two types of products, a renewable term life insurance product providing a lump sum benefit to the beneficiary on death of an employee; and a group dependent life product which provides an annuity to the beneficiary on death of an employee. Both coverages are frequently linked to employees’ wages. Individual Disability: Individual disability is offered primarily to individual retail customers. Individual disability insurance provides the insured with a portion of earned income lost as a result of sickness or injury. Under an individual disability policy, monthly benefits generally are fixed at the time the policy is written. The benefits typically range from 30 percent to 50 percent of the insured’s monthly earned income. The company’s underwriters evaluate the medical and financial condition of prospective policyholders prior to the issuance of a policy. Critical Illness: Group critical illness products are sold to groups of employees. Individual critical illness products are offered to individual retail customers. Critical illness products provide a lump-sum benefit on the occurrence of a covered critical illness event. Voluntary Benefits: The product offering includes group disability, group life, and group critical illness products. These products are sold to groups of employees through payroll deduction at the workplace. Policies include rate guarantees at inception and at renewal, generally for a period of two years. Colonial Life The Colonial Life segment includes insurance for accident, sickness, and disability products, life products, and cancer and critical illness products issued primarily by Colonial Life & Accident Insurance Company and marketed to employees at the workplace through an agency sales force and brokers. Accident, Sickness, and Disability: The accident, sickness, and disability product line consists of short-term disability plans as well as accident-only plans providing benefits for injuries on a specified loss basis. It also includes accident and health plans covering hospital admissions, confinement, and surgeries on an indemnity basis and group limited benefit medical plans which provide limited indemnity benefits for basic healthcare expenses. Life: Group and individual life products primarily comprise universal life, whole life, level term life, and a block of group term life policies. Cancer and Critical Illness: Cancer policies provide various benefits for the treatment of cancer, including hospitalization, surgery, radiation, and chemotherapy. Critical illness policies provide a lump-sum benefit on the occurrence of a covered critical illness event. Closed Block The Closed Block segment consists of individual disability, group and individual long-term care, and other insurance products no longer actively marketed. Individual Disability: These products consist of those individual disability policies in-force before the substantial changes in product offerings, pricing, distribution, and underwriting, which occurred during the period 1994 through 1998. The majority of the policies represent individual disability insurance which was written on a noncancelable basis. Group and Individual Long-term Care: The company announced in February 2012 that it would discontinue selling